首页> 外国专利> DIAGNOSTIC METHOD OF CLINICALLY SIGNIFICANT PROSTATE CANCER

DIAGNOSTIC METHOD OF CLINICALLY SIGNIFICANT PROSTATE CANCER

机译:临床上意义重大的前列腺癌的诊断方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to oncology, urology, and roentgen diagnostics, and can be used to diagnose clinically significant prostate cancer. Multiparametric magnetic resonance imaging of the pelvic organs, a standard 12-core biopsy of the prostate gland is carried out before the prostate biopsy. Additionally three-dimensional pulse sequence 3D-Cube performed with magnetic resonance imaging. Process the received MR data at the GEAW 4.7 VolumeShare7 workstation in the reformat and readyview programs. Mark layers of the prostate gland, urethra, seminal vesicles and lesions suspicious of the presence of clinically significant cancer, each of which is marked into a separate figure and saved as a 3D model in STL format. Combine the obtained models in real volume on a personal computer in the Meshlab 2016 program into a single 3D model. In the final 3D model, the prostate gland is labeled transparent, the urethra and the seminal vesicles in white. And foci depending on the scores as per PiRads v2.0 are labeled as follows: 3 points – green, 4 points – yellow and 5 points – red. Model is saved and used as a visual three-dimensional image of the volume, size and localization of prostate foci. Measure the distance from any part – the urethra, capsules, apex, base, anterior section of the prostate – to the focus. On the basis of a visual analysis of a spatial 3D model, in addition to the standard 12-core biopsy, 2 additional injections are made in each prostate gland graduated according to the PiRads scale ≥ 3.;EFFECT: method provides improved diagnostics of clinically significant prostate cancer by labeling and measuring in a single 3D model in the STL format, obtained by multiparameter magnetic resonance imaging of pelvic organs, and in addition to the standard 12-core biopsy, 2 additional injections in each prostate focus.;1 cl, 2 ex
机译:技术领域本发明涉及医学,即涉及肿瘤学,泌尿科和伦琴诊断学,并且可以用于诊断临床上重要的前列腺癌。盆腔器官的多参数磁共振成像是在进行前列腺活检之前对前列腺进行的12核标准活检。另外,利用磁共振成像执行三维脉冲序列3D-Cube。在重新格式化和readyview程序中,在GEAW 4.7 VolumeShare7工作站上处理接收到的MR数据。标记怀疑存在临床上显着癌症的前列腺,尿道,精囊和病变层,将每个层标记为单独的图形并以STL格式保存为3D模型。在Meshlab 2016程序中,在个人计算机上将获得的模型真实地合并为一个3D模型。在最终的3D模型中,前列腺标记为透明,尿道和精囊标记为白色。根据PiRads v2.0的得分,重点标记如下:3分–绿色,4分–黄色和5分–红色。保存模型并将其用作前列腺灶的体积,大小和位置的可视三维图像。测量从任何部位(尿道,胶囊,顶点,基部,前列腺前段)到焦点的距离。在对空间3D模型进行视觉分析的基础上,除了标准的12芯活检,还根据PiRads评分≥3对每个前列腺进行了2次额外注射;效果:该方法可改善临床诊断通过以骨盆器官的多参数磁共振成像获得的STL格式在单个3D模型中进行标记和测量,从而获得显着的前列腺癌;除标准的12芯活检外,每个前列腺聚焦点还需再注射2次; 1 cl, 2前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号